IGBA Picks Apart Innovator Patent ‘Gaming Systems’
A New Report Illustrates Strategies Delaying Or Blocking Off-Patent Competition
The International Generic and Biosimilar Medicines Association has introduced its first global intellectual property and competition report, addressing the urgent need to reform current regulations. But, in a bid to increase access to medicines across the world, did it stop short at just IP and patents?
